Limited data exist on economic burden of rotavirus gastroenteritis
in Libya. Aim of this study is to perform cost analysis of rotavirus disease
in Libya. A prospective cross sectional study was conducted among rotavirus
children aged below five years from August 2012 to April 2013 at three public
hospitals in Libya. The cost of rotavirus treatment is calculated the cost of
rotavirus treatment from the hospital and patients
perspective for hospitalized and ambulatory case. A total of 311 patients were
enrolled in this study. Of these 239 cases were inpatients while 72 cases were
outpatients. The average treatment cost of a hospitalized rotavirus episode
was US$ 667.76 and out of this US$ 480.36 (72%) was by the hospital, while US$
187.40 (28%) by the patient. The average cost of treatment for ambulatory rotavirus
case was US$ 166.34, of which US$ 120.02 (72%) was from hospital cost and US$
46.32 (28%) from patients cost.
These costs for inpatient and outpatient were during the whole treatment period.
Hospital and patients cost of
rotavirus treatment showed the disease posed a considerable economic burden
on Libyan government and families. Applying preventive measures would be more
appropriate such as introducing rotavirus immunization to reduce the disease.